Alumis draws Outperform at Oppenheimer on valuation disconnect

Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation and a 12–18-month price target of $32 on Thursday, noting that despite the potential in its pipeline, the company continues to trade near its cash level.

Arguing that liquidity